Tailoring Long-Lived Charge Separation Enables Efficient Light-to-Heat Conversion for Efficient Cancer Therapy

Area of Science:

• Biomedical Engineering
• Materials Science
• Organic Chemistry

Background:

• Photothermal therapy (PTT) uses light-activated materials to generate heat for cancer treatment.
• Low photothermal conversion efficiency (PCE) in organic materials necessitates high laser powers, limiting clinical use.
• Developing efficient organic photothermal agents is crucial for safer, targeted cancer therapy.

Purpose of the Study:

• To present a molecular design strategy for highly efficient organic photothermal agents.
• To engineer organic molecules with enhanced light-to-heat conversion capabilities.
• To evaluate the therapeutic efficacy and immunomodulatory effects of a novel material in a preclinical cancer model.

Main Methods:

• Molecular engineering of organic compounds to achieve charge separation and prolonged energy storage.
• Synthesis and characterization of a novel material (MNTPAA) with optimized photothermal properties.
• In vivo evaluation of MNTPAA-mediated photothermal therapy in a mouse model of aggressive breast tumors.

Main Results:

• The engineered material MNTPAA demonstrated a high PCE of 91.47% under near-infrared (NIR) light.
• MNTPAA/NIR treatment successfully eradicated aggressive breast tumors in mice.
• The treatment also stimulated an anti-tumor immune response, preventing cancer recurrence.

Conclusions:

• A molecular design strategy enabling efficient photothermal conversion was successfully developed.
• The novel material MNTPAA shows significant promise as a potent photothermal agent for cancer therapy.
• This approach facilitates the design of advanced materials for enhanced therapeutic efficacy and immunomodulation.